Scientific Sessions 2025  /  Cool Clinical Cases in Cardiomyopathies  /  Corheart 6 Ultracompact Magnetically Levitated Left Ventricular Assist Device in a Patient with Obese Heart Failure
Logo

American Heart Association

  106
  0

Final ID: Mo3087

Corheart 6 Ultracompact Magnetically Levitated Left Ventricular Assist Device in a Patient with Obese Heart Failure

Abstract Body (Do not enter title and authors here): Due to the critical shortage of cardiac transplant donors, durable left ventricular assist device (LVAD) has become an effective alternative therapy for end-stage heart failure (ESHF). Miniaturization of LVAD holds significant clinical implications. This report describes the clinical application of the novel 90-gram Corheart 6 ultra-compact axial-flow magnetically levitated LVAD. A 55-year-old male patient with ESHF and high-body mass index (BMI) successfully underwent Corheart 6 implantation. During the 601-day follow-up period, no device-related adverse events were observed. The successful application in this high-BMI patient demonstrates the excellent stability of the Corheart 6 miniaturized magnetically levitated LVAD, highlighting its potential for future minimally invasive implantation techniques and pediatric applications
  • Jia, Songhao  ( Beijing Anzhen Hospital , Beijing , China )
  • Gong, Ming  ( Beijing Anzhen Hospital , Beijing , China )
    • Author Disclosures:
    Songhao Jia: DO NOT have relevant financial relationships | Ming Gong: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cool Clinical Cases in Cardiomyopathies

Monday, 11/10/2025 , 01:00PM - 02:00PM

Abstract Poster Board Session

More abstracts on this topic:
Cell-free DNA Analysis Profiles End-Organ Injury and Predicts Outcomes with Left Ventricular Assist Device Implantation

Park Ashley, Rodrigo Maria, Shah Keyur, Valantine Hannah, Shah Palak, Agbor-enoh Sean, Andargie Temesgen, Hill Tom, Redekar Neelam, Tian Xin, Park Woojin, Kong Hyesik, Cavagna Isabella, Jang Moon

β1-adrenergic autoantibodies (β1-AA) augment macropinocytosis in CD4+ T cells, leading to the expansion of CD4+CD28− T cell subsets in heart failure.

Sun Fei, Yao Junyan, Li Bingjie, Zhang Suli, Liu Huirong

More abstracts from these authors:
Mitral Repair Versus Mechanical Replacement in Rheumatic Patients Under 65: Outcomes in the Era of The Whole-Life Cycle for Valvular Heart Disease

Jia Songhao, Zhang Hongjia, Jiang Wenjian

4358833_File000000.jpg
4358833_File000000.jpg
4358833_File000001.jpg
4358833_File000001.jpg
4358833_File000002.jpg
4358833_File000002.jpg
You have to be authorized to contact abstract author. Please, Login
Not Available